These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
284 related articles for article (PubMed ID: 24319409)
1. A cholinergic hypothesis of the unconscious in affective disorders. Vakalopoulos C Front Neurosci; 2013; 7():220. PubMed ID: 24319409 [TBL] [Abstract][Full Text] [Related]
2. Neurocognitive deficits in major depression and a new theory of ADHD: a model of impaired antagonism of cholinergic-mediated prepotent behaviours in monoamine depleted individuals. Vakalopoulos C Med Hypotheses; 2007; 68(1):210-21. PubMed ID: 16997497 [TBL] [Abstract][Full Text] [Related]
3. Neuropharmacology of cognition and memory: a unifying theory of neuromodulator imbalance in psychiatry and amnesia. Vakalopoulos C Med Hypotheses; 2006; 66(2):394-431. PubMed ID: 16300905 [TBL] [Abstract][Full Text] [Related]
4. Alzheimer's disease: more than a 'cholinergic disorder' - evidence that cholinergic-monoaminergic interactions contribute to EEG slowing and dementia. Dringenberg HC Behav Brain Res; 2000 Nov; 115(2):235-49. PubMed ID: 11000423 [TBL] [Abstract][Full Text] [Related]
5. 192IGG-saporin-induced selective lesion of cholinergic basal forebrain system: neurochemical effects on cholinergic neurotransmission in rat cerebral cortex and hippocampus. Rossner S; Schliebs R; Härtig W; Bigl V Brain Res Bull; 1995; 38(4):371-81. PubMed ID: 8535860 [TBL] [Abstract][Full Text] [Related]
6. Counteractive effects of a partial (sabcomeline) and a full (RS86) muscarinic receptor agonist on deficits in radial maze performance induced by S-AMPA lesions of the basal forebrain and medial septal area. Hodges H; Peters S; Gray JA; Hunter AJ Behav Brain Res; 1999 Feb; 99(1):81-92. PubMed ID: 10512575 [TBL] [Abstract][Full Text] [Related]
7. Cadmium-induced cell death of basal forebrain cholinergic neurons mediated by muscarinic M1 receptor blockade, increase in GSK-3β enzyme, β-amyloid and tau protein levels. Del Pino J; Zeballos G; Anadón MJ; Moyano P; Díaz MJ; García JM; Frejo MT Arch Toxicol; 2016 May; 90(5):1081-92. PubMed ID: 26026611 [TBL] [Abstract][Full Text] [Related]
8. [Selective stimulations and lesions of the rat brain nuclei as the models for research of the human sleep pathology mechanisms]. Šaponjić J Glas Srp Akad Nauka Med; 2011; (51):85-97. PubMed ID: 22165729 [TBL] [Abstract][Full Text] [Related]
9. Effects of cholinergic-rich neural grafts on radial maze performance of rats after excitotoxic lesions of the forebrain cholinergic projection system--I. Amelioration of cognitive deficits by transplants into cortex and hippocampus but not into basal forebrain. Hodges H; Allen Y; Kershaw T; Lantos PL; Gray JA; Sinden J Neuroscience; 1991; 45(3):587-607. PubMed ID: 1775235 [TBL] [Abstract][Full Text] [Related]
10. Spatial memory deficits in aged rats: contributions of monoaminergic systems. Luine V; Bowling D; Hearns M Brain Res; 1990 Dec; 537(1-2):271-8. PubMed ID: 2085779 [TBL] [Abstract][Full Text] [Related]
12. Agonist-induced restoration of hippocampal neurogenesis and cognitive improvement in a model of cholinergic denervation. Van Kampen JM; Eckman CB Neuropharmacology; 2010 May; 58(6):921-9. PubMed ID: 20026137 [TBL] [Abstract][Full Text] [Related]
13. Cholinergic system and memory in the rat: effects of chronic ethanol, embryonic basal forebrain brain transplants and excitotoxic lesions of cholinergic basal forebrain projection system. Arendt T; Allen Y; Marchbanks RM; Schugens MM; Sinden J; Lantos PL; Gray JA Neuroscience; 1989; 33(3):435-62. PubMed ID: 2636702 [TBL] [Abstract][Full Text] [Related]
14. M1 muscarinic receptors facilitate hippocampus-dependent cognitive flexibility via modulating GluA2 subunit of AMPA receptors. Xiong CH; Liu MG; Zhao LX; Chen MW; Tang L; Yan YH; Chen HZ; Qiu Y Neuropharmacology; 2019 Mar; 146():242-251. PubMed ID: 30529302 [TBL] [Abstract][Full Text] [Related]
15. The role of the central cholinergic projections in cognition: implications of the effects of scopolamine on discrimination learning by monkeys. Harder JA; Baker HF; Ridley RM Brain Res Bull; 1998; 45(3):319-26. PubMed ID: 9510426 [TBL] [Abstract][Full Text] [Related]
16. The potential for muscarinic receptor subtype-specific pharmacotherapy for Alzheimer's disease. McKinney M; Coyle JT Mayo Clin Proc; 1991 Dec; 66(12):1225-37. PubMed ID: 1749291 [TBL] [Abstract][Full Text] [Related]
17. Effects of lesion of the cholinergic basal forebrain nuclei on the activity of glutamatergic and GABAergic systems in the rat frontal cortex and hippocampus. Reine G; Samuel D; Nieoullon A; Kerkerian-Le Goff L J Neural Transm Gen Sect; 1992; 87(3):175-92. PubMed ID: 1581017 [TBL] [Abstract][Full Text] [Related]
18. [Neurochemical mechanisms of sleep regulation]. Glas Srp Akad Nauka Med; 2009; (50):97-109. PubMed ID: 20666118 [TBL] [Abstract][Full Text] [Related]